We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ATRC market cap is 1.75B. The company's latest EPS is USD -0.6243 and P/E is -57.62.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 98.29M | 106.54M | 108.85M | 116.27M | 115.91M |
Operating Income | -8.09M | -8.67M | -10.92M | -7.17M | -7.41M |
Net Income | -9.06M | -9.79M | -13.27M | -8.01M | -7.85M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 230.81M | 206.53M | 274.33M | 330.38M | 399.25M |
Operating Income | -33.12M | -44.23M | -129.6M | -42.67M | -26.68M |
Net Income | -35.19M | -48.16M | 50.2M | -46.47M | -30.44M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 600.27M | 613.93M | 591.63M | 597.27M | 615.07M |
Total Liabilities | 137.44M | 147.76M | 135.32M | 135.19M | 150.05M |
Total Equity | 462.83M | 466.17M | 456.31M | 462.09M | 465.02M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 557.88M | 714.54M | 615.31M | 585.45M | 613.93M |
Total Liabilities | 310.54M | 302.15M | 131.56M | 128.69M | 147.76M |
Total Equity | 247.34M | 412.39M | 483.76M | 456.75M | 466.17M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 454k | 4.48M | -21.02M | -13.64M | 6.37M |
Investing | 24.6M | 21.82M | 9.64M | 40.54M | 44.93M |
Financing | -2.39M | -32k | -7.86M | -5.01M | -5.34M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -15.81M | -19.87M | -13.78M | -22.14M | 4.48M |
Investing | -2.15M | -156.2M | 23.5M | 44.01M | 21.82M |
Financing | 14.37M | 189.39M | -7.64M | -7.06M | -32k |
Market Cap | 1.75B |
Price to Earnings Ratio | -57.62 |
Price to Sales Ratio | 4.39 |
Price to Cash Ratio | 20.8 |
Price to Book Ratio | 3.76 |
Dividend Yield | - |
Shares Outstanding | 48.75M |
Average Volume (1 week) | 435.76k |
Average Volume (1 Month) | 710.73k |
52 Week Change | -6.30% |
52 Week High | 42.9999 |
52 Week Low | 18.94 |
Spread (Intraday) | 0.04 (0.11%) |
Company Name | AtriCure Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.atricure.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions